.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Chubb
Harvard Business School
UBS
Argus Health
US Department of Justice
Dow
Express Scripts
Accenture
Baxter

Generated: June 24, 2017

DrugPatentWatch Database Preview

MARCAINE HYDROCHLORIDE PRESERVATIVE FREE Drug Profile

« Back to Dashboard

What is the patent landscape for Marcaine Hydrochloride Preservative Free, and what generic Marcaine Hydrochloride Preservative Free alternatives are available?

Marcaine Hydrochloride Preservative Free is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in MARCAINE HYDROCHLORIDE PRESERVATIVE FREE is bupivacaine hydrochloride. There are ten drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride profile page.

Summary for Tradename: MARCAINE HYDROCHLORIDE PRESERVATIVE FREE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list8
Clinical Trials: see list10,713
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MARCAINE HYDROCHLORIDE PRESERVATIVE FREE at DailyMed

Pharmacology for Tradename: MARCAINE HYDROCHLORIDE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE
bupivacaine hydrochloride
INJECTABLE;INJECTION016964-012Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Hospira
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE
bupivacaine hydrochloride
INJECTABLE;INJECTION016964-005Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
Hospira
MARCAINE HYDROCHLORIDE PRESERVATIVE FREE
bupivacaine hydrochloride
INJECTABLE;INJECTION016964-009Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
AstraZeneca
Cipla
Covington
Chinese Patent Office
Citi
Deloitte
Chubb
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot